$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How long does it usually take for patients to become resistant to furmonertinib and analysis of the causes
2026-02-01 22:25:32
Check Details
Summary of clinical efficacy and patient feedback of ensifentrine-Ohtuvayre in the treatment of chronic obstructive pulmonary disease
2026-02-01 22:25:32
Check Details
Analysis of the reasons why people dare not stop taking Roaccutane (isotretinoin) easily after taking it for three years
2026-02-01 22:25:32
Check Details
Comparison of the advantages and disadvantages of whether Doxorubicin or Paclitaxel is more suitable for treating different cancers
2026-02-01 22:25:32
Check Details
Detailed explanation of contraindications and drug risks for patients with Everolimus (Afinitor)
2026-02-01 22:25:32
Check Details
Analysis of the mechanism of action of estramustine and its effect on tumor cells
2026-02-01 22:25:32
Check Details
Whether seripase (BRINEURA) has been included in the medical insurance policy and the introduction of medical insurance reimbursement
2026-02-01 22:25:32
Check Details
Analysis of whether Eslicarbazepine has been launched in China and its market supply situation
2026-02-01 22:25:32
Check Details
Where can I buy Anagrelide? Regular purchasing channels and precautions
2026-02-01 22:25:32
Check Details
Interpretation of whether apalutamide has been included in medical insurance and medical insurance reimbursement policy
2026-02-01 22:25:32
Check Details
What diseases is Elacetrant mainly used to treat and its clinical scope of application?
2026-02-01 22:25:32
Check Details
What is the approximate price of a box of Nintedanib on the market?
2026-02-01 22:25:32
Check Details
1
2
...
2143
2144
2145
2146
2147
2148
2149
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma